Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.

[1]  Srinivasan Keshav,et al.  How to read a paper , 2007, CCRV.

[2]  M. J. van de Vijver,et al.  Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy , 2006, Clinical Cancer Research.

[3]  M. West,et al.  Genomic prediction of locoregional recurrence after mastectomy in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Vinayagam,et al.  Genomic analysis of Xenopus organizer function , 2006, BMC Developmental Biology.

[5]  C. Grau,et al.  Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Grau,et al.  Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  M. J. van de Vijver,et al.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.

[8]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[9]  R. Gelber,et al.  Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  C. Grau,et al.  Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  T. Whelan,et al.  More evidence that locoregional radiation therapy improves survival: what should we do? , 2005, Journal of the National Cancer Institute.

[12]  John J Spinelli,et al.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. , 2005, Journal of the National Cancer Institute.

[13]  T. Whelan,et al.  Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy , 2004, Canadian Medical Association Journal.

[14]  R. Gelber,et al.  Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J. Kurtz.  The curative role of radiotherapy in the treatment of operable breast cancer. , 2002, European journal of cancer.

[16]  M. Overgaard,et al.  Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer. , 2001, European journal of cancer.

[17]  Robert J. Mayer,et al.  National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.

[18]  J. Lagendijk,et al.  The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1). , 2001, International journal of radiation oncology, biology, physics.

[19]  S. Edge,et al.  Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  H. Bartelink,et al.  Breast cancer survival advantage with radiotherapy , 2000, The Lancet.

[21]  J. Overgaard,et al.  Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone , 2000 .

[22]  J. Overgaard,et al.  Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials , 1999, The Lancet.

[23]  N. Robert,et al.  Consensus Statement on postmastectomy radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[24]  B. Rasmussen,et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.

[25]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[26]  R. Grol,et al.  Personal paper: Beliefs and evidence in changing clinical practice , 1997 .

[27]  R. Gelber,et al.  Improved methodology for analyzing local and distant recurrence. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Harold C. Sox,et al.  National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making , 1988 .

[29]  J. Kurtz.  Position Paper EUSOMA Guidelines The curative role of radiotherapy in the treatment of operable breast cancer , 2002 .